Saltar al contenido principal Saltar al pie de página
CLICAP
  • Inicio
  • Nosotros
  • Eventos
  • Inicio
  • Nosotros
  • Eventos
  • Inicio
  • Nosotros
  • Eventos
  • Biblioteca
  • Inicio
  • Nosotros
  • Eventos
  • Biblioteca
Estudios e Investigaciones
Recursos para profesionales de la salud

Destacados

Estudios

PD-L1 expression complements CALGB prognostic scoring system in malignant pleural mesothelioma

Frontiers in Oncology | 2023
Estudios
Imagen 1 sección nosotros

EP12.03-04 Prognostic Value of TP53 Commutations Among Hispanic Patients with Advanced EGFR-positive NSCLC Treated with First Line Osimertinib

Journal of Thoracic Oncology | 2023
Estudios

EP12.01-65 Prognostic Value of Sequential Liquid Biopsy (LB) after Osimertinib Among Hispanic Patients with Advanced EGFR-Mutant NSCLC

Journal of Thoracic Oncology | 2023
Estudios

Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer

Frontiers in Oncology | 2023
Estudios

Real-world Study on Efficacy of First-Line Nivolumab + Ipilimumab in Unresectable Malignant Pleural Mesothelioma (ImmunoMeso)

Journal of Thoracic Oncology | 2023
Estudios

Characteristics and Outcomes of Hispanic Patients with RET-Fusion Positive NSCLC Treated in Real-World Practice

Journal of Thoracic Oncology | 2023
Recursos para profesionales de la salud

Biblioteca

Ordenar
Categoría
Investigaciónes

EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)

Targ Oncol | 2018

Investigaciónes

Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer

Clinical Lung Cancer | 2021

Investigaciónes

Characteristics and outcomes of thymomas in Latin America:Results from over 10 years of experience (CLICaP-LATimus)

Thoracic Cancer | 2021

Investigaciónes

EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)

JCO Precision Oncology | 2021

Investigaciónes

Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin America

Global Oncology | 2020

Investigaciónes

Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP)

Thoracic Cancer | 2020

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Siguiente »
Bricks Blog Site
  • Nosotros
  • Eventos
  • Biblioteca
  • Contacto

Copyright 2024 CLICAP | Designed & Developed by Prome-Tech